Omega Therapeutics had a revenue of 2.61M in the quarter ending Sep 30, 2024, with 22.40%. This bring the company's revenue in the last twelve months to 8.10M, Decreased 28.21%. In the fiscal year ending Dec 31, 2023, Omega Therapeutics had annual revenue of 3.09M with 49.25% growth.